Oric Pharmaceuticals, Inc. (ORIC) earnings
ORIC earnings moved a median of +1.70% by the close. Quarterly and annual ORIC reports and results, each read against the price at its own news timestamp. Back to the ORIC overview →
19 measured ORIC earnings events.
Where these ORIC earnings landedvs 19 measured ORIC earnings reactions
| Middle 50% of ORIC earnings reactions | +0.39% to +4.92% |
|---|---|
| Median reaction (to close) | +1.70% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ORIC earnings events with a measured close landed between +0.39% and +4.92%; 79% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Oric Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +2.40% | +26.60% | |
| ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates | Press release | +2.40% | +26.60% | |
| Form 10-Q Oric Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.42% | +1.70% | |
| ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates | Press release | +0.42% | +1.70% | |
| Form 10-K Oric Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.41% | +11.09% | |
| Form 10-Q Oric Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +3.24% | +2.82% | |
| ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates | Press release | +3.24% | +2.82% | |
| Form 10-Q Oric Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.14% | -13.55% | |
| ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates | Press release | -2.14% | -13.55% | |
| Form 10-K Oric Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -6.77% | -7.35% | |
| Form 10-Q Oric Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.15% | +0.39% | |
| ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates | Press release | -0.15% | +0.39% | |
| Form 10-Q Oric Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +1.15% | +7.02% | |
| ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates | Press release | +1.15% | +7.02% | |
| Form 10-Q Oric Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +6.47% | +1.80% | |
| ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates | Press release | +6.47% | +1.80% | |
| Form 10-K Oric Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.48% | -2.12% | |
| Form 10-Q Oric Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +2.79% | +0.73% | |
| ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates | Press release | +2.79% | +0.73% |
Keep exploring
More ORIC: analyst actions → · SEC filings → · ORIC overview →